HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshiko Furukawa Selected Research

aurapten

1/2021[Search for Neuroprotective Compounds -From 4-Methycatechol to Citrus Compounds].
3/2020Citrus Auraptene Induces Expression of Brain-Derived Neurotrophic Factor in Neuro2a Cells.
1/2020[Neuroprotective effects of the peel of Citrus kawachiensis (Kawachi Bankan) and auraptene in the hippocampus of hyperglycemia mice and global cerebral ischemia/reperfusion injury mice].
12/2019Citrus Auraptene Induces Glial Cell Line-Derived Neurotrophic Factor in C6 Cells.
1/2019Continual Treatment with the Peels of Citrus kawachiensis (Kawachi Bankan) Protects against Dopaminergic Neuronal Cell Death in a Lipopolysaccharide-Induced Model of Parkinson's Disease.
1/2019Auraptene/Naringin-Rich Fruit Juice of Citrus kawachiensis (Kawachi Bankan) Prevents Ischemia-Induced Neuronal Cell Death in Mouse Brain through Anti-Inflammatory Responses.
8/2018Inhibitory Effects of Auraptene and Naringin on Astroglial Activation, Tau Hyperphosphorylation, and Suppression of Neurogenesis in the Hippocampus of Streptozotocin-Induced Hyperglycemic Mice.
10/2016Auraptene and Other Prenyloxyphenylpropanoids Suppress Microglial Activation and Dopaminergic Neuronal Cell Death in a Lipopolysaccharide-Induced Model of Parkinson's Disease.
1/2016Auraptene induces oligodendrocyte lineage precursor cells in a cuprizone-induced animal model of demyelination.
1/2014Auraptene in the Peels of Citrus kawachiensis (Kawachi Bankan) Ameliorates Lipopolysaccharide-Induced Inflammation in the Mouse Brain.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshiko Furukawa Research Topics

Disease

12Inflammation (Inflammations)
01/2021 - 10/2005
8Ischemia
01/2021 - 10/2012
6Brain Ischemia (Cerebral Ischemia)
01/2021 - 10/2012
5Dementia (Dementias)
03/2012 - 07/2002
4Parkinson Disease (Parkinson's Disease)
08/2019 - 09/2009
4Alzheimer Disease (Alzheimer's Disease)
08/2019 - 12/2009
4Body Weight (Weight, Body)
10/2017 - 01/2014
3Glioma (Gliomas)
03/2020 - 08/2019
3Hyperglycemia
01/2020 - 08/2018
3Pick Disease of the Brain (Pick's Disease)
06/2007 - 03/2004
2Cognitive Dysfunction
01/2021 - 01/2021
2Reperfusion Injury
01/2020 - 07/2018
2Chronic Pain
08/2019 - 11/2014
2Mental Disorders (Mental Disorder)
12/2016 - 12/2010
2Demyelinating Diseases (Demyelinating Disease)
01/2016 - 11/2013
2Mood Disorders (Mood Disorder)
03/2015 - 01/2013
2Neurodegenerative Diseases (Neurodegenerative Disease)
09/2009 - 10/2004
2Frontotemporal Dementia (Semantic Dementia)
12/2007 - 06/2007
2Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
12/2007 - 06/2007
2Spinal Cord Injuries (Spinal Cord Injury)
12/2007 - 06/2002
2Motor Neuron Disease (Primary Lateral Sclerosis)
06/2007 - 12/2004
1Familial Primary Pulmonary Hypertension
07/2021
1Pulmonary Arterial Hypertension
07/2021
1Neoplasms (Cancer)
05/2021
1Infections
05/2021
1Mitochondrial Diseases (Mitochondrial Disease)
01/2021
1Neuroblastoma
03/2020
1Delirium
01/2020
1Brain Diseases (Brain Disorder)
12/2019
1Central Nervous System Diseases (CNS Diseases)
08/2019
1Epilepsy (Aura)
08/2019
1Brain Injuries (Brain Injury)
04/2019
1Cardiac Arrhythmias (Arrythmia)
08/2018
1Ventricular Tachycardia
08/2018
1Stroke (Strokes)
04/2015
1Memory Disorders (Memory Loss)
04/2015
1Pain (Aches)
11/2014
1Neuromyelitis Optica (Devic's Disease)
11/2013
1Multiple Sclerosis
11/2013
1Neuroinflammatory Diseases
05/2013

Drug/Important Bio-Agent (IBA)

12Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 10/2012
11auraptenIBA
01/2021 - 01/2013
10Proteins (Proteins, Gene)FDA Link
07/2021 - 03/2004
8LipopolysaccharidesIBA
01/2019 - 10/2005
7Neuroprotective AgentsIBA
03/2020 - 01/2013
5Nerve Growth Factors (Neurotrophins)IBA
01/2021 - 12/2007
5Messenger RNA (mRNA)IBA
03/2020 - 10/2012
5PowdersIBA
01/2020 - 01/2014
5UbiquitinIBA
12/2007 - 01/2003
4FlavonoidsIBA
01/2021 - 10/2012
4Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
03/2020 - 10/2005
43,3',4',5,6,7,8-heptamethoxyflavoneIBA
04/2016 - 10/2012
3Phosphotransferases (Kinase)IBA
03/2020 - 09/2009
3Streptozocin (Streptozotocin)FDA Link
01/2020 - 08/2018
3naringinIBA
01/2019 - 07/2018
3Calcium-Calmodulin-Dependent Protein KinasesIBA
07/2018 - 04/2015
3AntibodiesIBA
04/2011 - 07/2002
2oenothein BIBA
05/2021 - 05/2013
2Ointments (Pastes)IBA
01/2021 - 01/2021
2Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
03/2020 - 10/2012
2coumarinIBA
12/2019 - 01/2013
2CorticosteroneIBA
04/2016 - 03/2015
2CuprizoneIBA
01/2016 - 11/2013
2Pharmaceutical PreparationsIBA
04/2015 - 03/2015
2Lysosomal-Associated Membrane Protein 2IBA
04/2011 - 09/2009
2Presenilin-1IBA
03/2011 - 12/2009
2DNA-Binding Proteins (DNA Binding Protein)IBA
12/2007 - 06/2007
1ellagitanninIBA
05/2021
1glansreginin AIBA
01/2020
1Lidocaine (Xylocaine)FDA LinkGeneric
08/2018
1Glutathione (Reduced Glutathione)IBA
07/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2018
1MitogensIBA
10/2017
1U 0126 (UO 126)IBA
10/2017
1Cholinergic Agents (Cholinergics)IBA
12/2016
1FlavonesIBA
04/2015
1flavoneIBA
04/2015
1AntioxidantsIBA
04/2015
1EdaravoneIBA
04/2015
1Fluvoxamine (Luvox)FDA LinkGeneric
03/2015
1Antidepressive Agents (Antidepressants)IBA
11/2014
1Imipramine (Janimine)FDA LinkGeneric
11/2014
1Serotonin (5 Hydroxytryptamine)IBA
11/2014
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2014
1Kcnj10 (channel)IBA
11/2013
1AutoantibodiesIBA
11/2013
1CopperIBA
11/2013
1Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA
11/2013
1Aquaporins (Water Channels)IBA
11/2013
1Chelating AgentsIBA
11/2013
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2013
1Glial Fibrillary Acidic ProteinIBA
10/2012
1Intermediate Filament ProteinsIBA
10/2012
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2012

Therapy/Procedure

2Therapeutics
07/2021 - 04/2019
1Polypharmacy
01/2020
1Secondary Prevention
08/2018
1Oral Administration
10/2017
1Denervation
11/2014
1Analgesia
11/2014